Evaxion A (EVAX) Accumulated Depreciation & Amortization (2020 - 2021)
Evaxion A posted quarterly Accumulated Depreciation & Amortization of $5.3 million for Q4 2021, up 14902.78% year-on-year from N/an in Q4 2020, and up 14902.78% on a QoQ basis from -$36000.0 in Q4 2020.
Evaxion A (EVAX) has 2 years of Accumulated Depreciation & Amortization data on file, last reported at $5.3 million in Q4 2021.
- For the quarter ending Q4 2021, Accumulated Depreciation & Amortization rose 14902.78% year-over-year to $5.3 million; the trailing twelve-month figure through Dec 2021 stood at $5.3 million (up 14902.78% YoY), and the FY2021 full-year result was $5.3 million, up 14902.78% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2021 stood at $5.3 million, up from -$36000.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $5.3 million in Q4 2021 and bottomed at -$36000.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 5.33 Mn |
| Dec 31, 2021 | 5.33 Mn |
| Dec 31, 2020 | -36,000.00 |
| Dec 31, 2020 | -36,000.00 |